CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Fusarenone X
Accession: CHEBI:82577
browse the term
Definition: A trichothecene that has formula C17H22O8.
Synonyms: related_synonym: Formula=C17H22O8; Fusarenon-X; InChI=1S/C17H22O8/c1-7-4-9-16(5-18,12(22)10(7)20)15(3)13(24-8(2)19)11(21)14(25-9)17(15)6-23-17/h4,9,11-14,18,21-22H,5-6H2,1-3H3/t9-,11-,12-,13-,14-,15-,16-,17-/m1/s1; InChIKey=XGCUCFKWVIWWNW-UWKSZNKUSA-N; SMILES=CC(=O)O[C@@H]1[C@@H](O)[C@H]2O[C@@H]3C=C(C)C(=O)[C@@H](O)[C@]3(CO)[C@]1(C)[C@@]21CO1
xref: CAS:23255-69-8; KEGG:C19583
xref_mesh: MESH:C002469
G
Ar
androgen receptor
decreases activity
ISO
fusarenon-X results in decreased activity of AR protein
CTD
PMID:27481073
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Atf6
activating transcription factor 6
increases expression
ISO
fusarenon-X results in increased expression of ATF6 mRNA
CTD
PMID:20682335
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
fusarenon-X results in increased expression of BAD mRNA
CTD
PMID:24983900
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
fusarenon-X results in increased expression of BAX mRNA
CTD
PMID:24983900
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression decreases expression
ISO
fusarenon-X results in increased expression of BCL2 mRNA fusarenon-X results in decreased expression of BCL2 mRNA
CTD
PMID:24983900
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
increases expression
ISO
fusarenon-X results in increased expression of BCL2A1B mRNA
CTD
PMID:24983900
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
increases expression
ISO
fusarenon-X results in increased expression of BCL2L1 mRNA
CTD
PMID:24983900
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l2
Bcl2-like 2
increases expression
ISO
fusarenon-X results in increased expression of BCL2L2 mRNA
CTD
PMID:24983900
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
fusarenon-X results in decreased expression of BID mRNA
CTD
PMID:24983900
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Casp4
caspase 4
increases expression
ISO
fusarenon-X results in increased expression of CASP4 mRNA
CTD
PMID:24983900
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp8
caspase 8
increases expression
ISO
fusarenon-X results in increased expression of CASP8 mRNA
CTD
PMID:24983900
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression
ISO
fusarenon-X results in increased expression of CASP9 mRNA
CTD
PMID:24983900
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cck
cholecystokinin
increases expression
ISO
fusarenon-X results in increased expression of CCK protein
CTD
PMID:24385417
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO
fusarenon-X results in increased expression of CCL2 mRNA
CTD
PMID:24793808
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl7
C-C motif chemokine ligand 7
increases expression
ISO
fusarenon-X results in increased expression of CCL7 mRNA
CTD
PMID:24793808
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Cd40lg
CD40 ligand
decreases expression
ISO
fusarenon-X results in decreased expression of CD40LG mRNA
CTD
PMID:24983900
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
fusarenon-X results in increased expression of CXCL2 mRNA
CTD
PMID:24793808
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation
ISO
fusarenon-X results in increased phosphorylation of EIF2A protein
CTD
PMID:20682335
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
G
Fas
Fas cell surface death receptor
increases expression
ISO
fusarenon-X results in increased expression of FAS mRNA
CTD
PMID:24983900
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
decreases expression
ISO
fusarenon-X results in decreased expression of FASL mRNA
CTD
PMID:24983900
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gzmb
granzyme B
increases expression
ISO
fusarenon-X results in increased expression of GZMB mRNA
CTD
PMID:24983900
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Hspa5
heat shock protein family A (Hsp70) member 5
decreases expression
ISO
fusarenon-X results in decreased expression of HSPA5 mRNA
CTD
PMID:20682335
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Il1b
interleukin 1 beta
increases expression
ISO
fusarenon-X results in increased expression of IL1B mRNA
CTD
PMID:24793808
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
increases expression
ISO
fusarenon-X results in increased expression of IL6 mRNA
CTD
PMID:24793808
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf2
interferon regulatory factor 2
increases expression
ISO
fusarenon-X results in increased expression of IRF2 mRNA
CTD
PMID:24983900
NCBI chr16:45,439,215...45,550,054
Ensembl chr16:45,439,225...45,550,024
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
increases expression
ISO
fusarenon-X results in increased expression of MAP3K14 mRNA
CTD
PMID:24983900
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
G
Nfkbie
NFKB inhibitor epsilon
increases expression
ISO
fusarenon-X results in increased expression of NFKBIE mRNA
CTD
PMID:24983900
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Ngf
nerve growth factor
increases expression
ISO
fusarenon-X results in increased expression of NGF mRNA
CTD
PMID:24983900
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
decreases expression
ISO
fusarenon-X results in decreased expression of NGFR mRNA
CTD
PMID:24983900
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
fusarenon-X results in decreased expression of NR3C1 mRNA
CTD
PMID:24983900
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases activity
ISO
fusarenon-X results in decreased activity of PPARG protein
CTD
PMID:27481073
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
fusarenon-X results in increased expression of PTGS2 mRNA
CTD
PMID:14514436
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Tnf
tumor necrosis factor
increases expression
ISO
fusarenon-X results in increased expression of TNF mRNA
CTD
PMID:24793808 PMID:24983900
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
decreases expression
ISO
fusarenon-X results in decreased expression of TNFRSF10B mRNA
CTD
PMID:24983900
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf1b
TNF receptor superfamily member 1B
increases expression
ISO
fusarenon-X results in increased expression of TNFRSF1B mRNA
CTD
PMID:24983900
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
fusarenon-X results in increased expression of TNFSF10 mRNA
CTD
PMID:24983900
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
increases expression
ISO
fusarenon-X results in increased expression of TRP53 mRNA
CTD
PMID:24983900
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
decreases expression
ISO
fusarenon-X results in decreased expression of TRP63 mRNA
CTD
PMID:24983900
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tp73
tumor protein p73
increases expression
ISO
fusarenon-X results in increased expression of TRP73 mRNA
CTD
PMID:24983900
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
fusarenon-X results in increased expression of TRAF1 mRNA
CTD
PMID:24983900
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf3
Tnf receptor-associated factor 3
decreases expression
ISO
fusarenon-X results in decreased expression of TRAF3 mRNA
CTD
PMID:24983900
NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:130,206,484...130,305,481
G
Traf6
TNF receptor associated factor 6
increases expression
ISO
fusarenon-X results in increased expression of TRAF6 mRNA
CTD
PMID:24983900
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
fusarenon-X results in decreased expression of XIAP mRNA
CTD
PMID:24983900
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all